HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Risperidone in the treatment of autistic Thai children under 4 years of age.

Abstract
The authors report five cases of very young children with autistic disorder, aged 2.1-3.7 years, treated with risperidone, as part of the comprehensive intervention. Treatment with risperidone 0.25-0.5 mg per day was associated with clinically meaningful decreases in problem behaviors including hyperactivity, irritability, and aggressiveness. There were also improvements in social relatedness and cooperation with developmental treatment. All of the children tolerated the medication well and experienced no untoward effects. The efficacy of risperidone in the treatment of very young children with autistic disorder reported here is consistent with findings in the limited number of cases previously reported in the literature. Controlled studies are needed to confirm the efficacy and safety of risperidone in the treatment of these children.
AuthorsVitharon Boon-Yasidhi, Jariya Tarugsa, Chomyong Suwanwattana, Ladda Soising
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 85 Suppl 2 Pg. S784-9 (Aug 2002) ISSN: 0125-2208 [Print] Thailand
PMID12403261 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Dopamine Antagonists
  • Risperidone
Topics
  • Autistic Disorder (diagnosis, drug therapy)
  • Child, Preschool
  • Dopamine Antagonists (administration & dosage)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Follow-Up Studies
  • Humans
  • Male
  • Risperidone (administration & dosage)
  • Sampling Studies
  • Severity of Illness Index
  • Thailand
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: